The application of temperature-composition phase diagrams for hot melt extrusion processing of amorphous solid dispersions to prevent residual crystallinity-Reference-Cited by-同舟云学术

The application of temperature-composition phase diagrams for hot melt extrusion processing of amorphous solid dispersions to prevent residual crystallinity

Published:2018-12 Issue:1-2 Volume:553 Page:454-466
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Moseson Dana E.,Taylor Lynne S.

Funder

U.S. Food and Drug Administration

Purdue University

National Science Foundation

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference78 articles.

1. Rheology as a tool for evaluation of melt processability of innovative dosage forms;Aho;Int. J. Pharm.,2015

2. The flow properties and presence of crystals in drug-polymer mixtures: rheological investigation combined with light microscopy;Aho;Int. J. Pharm.,2017

3. Predicting solubility/miscibility in amorphous dispersions: it is time to move beyond regular solution theories;Anderson;J. Pharm. Sci.,2017

4. Poly-d-(-)(3-hydroxybutyrate)/poly(ethylene oxide) blends: phase diagram, thermal and crystallization behaviour;Avella;Polymer (Guildf.),1988

5. Evaluation of amorphous solid dispersion properties using thermal analysis techniques;Baird;Adv. Drug Deliv. Rev.,2012

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stoichiometric-dependent physical stability of atorvastatin-lisinopril co-amorphous in stress testing;Journal of Industrial and Engineering Chemistry;2024-11

2. Role of rheology in formulation and process design of hot melt extruded amorphous solid dispersions;International Journal of Pharmaceutics;2024-10

3. Developing an innovative 3D printing platform for production of personalised medicines in a hospital for the OPERA clinical trial;International Journal of Pharmaceutics;2024-08

4. Trends in amorphous solid dispersion drug products approved by the U.S. Food and Drug Administration between 2012 and 2023;International Journal of Pharmaceutics: X;2024-06

5. Materials for 3D Printing;3D Printing of Pharmaceutical and Drug Delivery Devices;2024-05-13